Skip to main content

Advertisement

Log in

18F-FDG PET/CT of hepatocellular adenoma subtypes and review of literature

  • Hepatobiliary
  • Published:
Abdominal Radiology Aims and scope Submit manuscript

Abstract

Introduction

This study evaluates 18F-FDG PET/CT imaging characteristics of pathologically proven hepatocellular adenoma (HCA) subtypes.

Methods

This is a retrospective review of an institutional database (2011–2017) for subjects with a pathologic diagnosis of hepatic adenomas established within 6 months of a pre-treatment 18F-FDG PET/CT exam. An expert pathological review by a hepatopathologist was performed to confirm diagnosis and subtype HCA. A review of the 18F-FDG PET/CT exams was performed by two board-certified nuclear radiologists in consensus. Corresponding demographic and clinical data were obtained by electronic chart review.

Results

Nine subjects were identified. An HCA subtype was established in seven subjects (4 HNF1A-mutated and 3 Inflammatory). The mean HCA lesion size was 2.8 cm (range 0.6–6.2, SD 2.0) with a mean SUVmax of 5.9 (range 2.1–18.9, SD 5.1). The SUV values of HNF1A-mutated HCA were significantly higher than inflammatory HCA: lesion SUVmax (5.3 ± 1.48 vs. 2.8 ± 0.59, p < 0.033), lesion-to-liver SUVmax ratio (1.4 ± 0.22 vs. 0.8 ± 0.21, p = 0.031), lesion SUVmean (3.6 ± 0.37 vs. 2.0 ± 0.46, p = 0.0086).

Conclusion

HNF1A-mutated HCA may have greater SUV values than inflammatory HCA on 18F-FDG PET/CT exams. However, there are contradictory data in the literature and further investigation is warranted.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Cho SW, Marsh JW, Steel J, et al. Surgical management of hepatocellular adenoma: take it or leave it? Ann Surg Oncol. 2008;15:2795-803.

    Article  Google Scholar 

  2. Stoot JH, Coelen RJ, De Jong MC, et al. Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases. HPB (Oxford). 2010;12:509-22.

    Article  Google Scholar 

  3. van Aalten SM, de Man RA, I. Jzermans JN, et al. Systematic review of haemorrhage and rupture of hepatocellular adenomas. Br J Surg. 2012;99:911–6.

  4. Bioulac-Sage P, Balabaud C, Zucman-Rossi J. Subtype classification of hepatocellular adenoma. Dig Surg. 2010;27:39-45.

    Article  CAS  Google Scholar 

  5. Nault JC, Couchy G, Balabaud C, et al. Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation. Gastroenterology. 2017;152:880-894.

    Article  CAS  Google Scholar 

  6. Young JT, Kurup AN, Graham RP, et al. Myxoid hepatocellular neoplasms: imaging appearance of a unique mucinous tumor variant. Abdominal Radiology. 2016; 41:2115-2122.

    Article  Google Scholar 

  7. Salaria SN, Graham RP, Aishima S, et al. Primary hepatic tumors with myxoid change: morphologically unique hepatic adenomas and hepatocellular carcinomas. Am J Surg Pathol. 2015;39:318-24.

    Article  Google Scholar 

  8. Mounajjed T, Yasir S, Aleff PA, et al. Pigmented hepatocellular adenomas have a high risk of atypia and malignancy. Mod Pathol. 2015;28:1265-74.

    Article  Google Scholar 

  9. Sumiyoshi T, Moriguchi M, Kanemoto H, et al. Liver-specific contrast agent-enhanced magnetic resonance and 18F-fluorodeoxyglucose positron emission tomography findings of hepatocellular adenoma: report of a case. Surg Today. 2012;42:200-4.

    Article  CAS  Google Scholar 

  10. Fosse P, Girault S, Hoareau J, et al. Unusual uptake of 1818F-FDG by a hepatic adenoma. Clin Nucl Med. 2013;38:135-6.

    Article  Google Scholar 

  11. Lim D, Lee SY, Lim KH, et al. Hepatic adenoma mimicking a metastatic lesion on computed tomography-positron emission tomography scan. World J Gastroenterol. 2013;19:4432-6.

    Article  Google Scholar 

  12. Nakashima T, Takayama Y, Nishie A, et al. Hepatocellular adenoma showing high uptake of (18)F-fluorodeoxyglucose (FDG ) via an increased expression of glucose transporter 2 (GLUT-2). Clin Imaging. 2014;38:888-91.

    Article  Google Scholar 

  13. Ozaki K, Harada K, Terayama N, et al. Hepatocyte nuclear factor 1alpha-inactivated hepatocellular adenomas exhibit high 18F-fludeoxyglucose uptake associated with glucose-6-phosphate transporter inactivation. British Journal of Radiology. 2016;89:1063.

    Google Scholar 

  14. Lee S, Kingham T, LaGratta M, et al. PET-avid hepatocellular adenomas: incidental findings associated with HNF1-α mutated lesions. HPB. 2016;18:41-48.

    Article  Google Scholar 

  15. Buc E, Dupre A, Golffier C, et al. Positive PET-CT scan in hepatocellular adenoma with concomitant benign liver tumors. Gastroenterol Clin Biol. 2010;34:338-41.

    Article  CAS  Google Scholar 

  16. Liu W, Delwaide J, Bletard N, et al. 18-Fluoro-deoxyglucose uptake in inflammatory hepatic adenoma: A case report. World J Hepatol. 2017;9:562-566.

    Article  Google Scholar 

  17. Sureka B, Rastogi A, Mukund A, et al. False-positive (18)F fluorodeoxyglucose positron emission tomography-avid benign hepatic tumor: Previously unreported in a male patient. Indian J Radiol Imaging. 2018;28:200-204.

    Article  Google Scholar 

  18. Patel PM, Alibazoglu H, Ali A, et al. 'False-positive' uptake of 18F-FDG in a hepatic adenoma. Clin Nucl Med. 1997;22:490-1.

    Article  CAS  Google Scholar 

  19. Delbeke D, Martin WH, Sandler MP, et al. Evaluation of benign vs malignant hepatic lesions with positron emission tomography. Arch Surg. 1998;133:510-5.

    Article  CAS  Google Scholar 

  20. Stephenson JA, Kapasi T, Al-Taan O, et al. Uptake of (18) 18F-FDG by a Hepatic Adenoma on Positron Emission Tomography. Case Reports Hepatol. 2011;276402:1-4.

    Article  Google Scholar 

  21. Sanli Y. Bakir B, Kuyumcu S, et al. Hepatic adenomatosis may mimic metastatic lesions of liver with 18F-FDG PET/CT. Clin Nucl Med. 2012;37:697-8.22.

    Google Scholar 

  22. Magini G, Farsad M, Frigerio M, et al. C-11 acetate does not enhance usefulness of 18F-FDG PET/CT in differentiating between focal nodular hyperplasia and hepatic adenoma. Clin Nucl Med. 2009;34:659-65.

    Article  Google Scholar 

  23. Zucman-Rossi J, Jeannot E, Nhieu JT, et al. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology. 2006;43:515-24.

    Article  CAS  Google Scholar 

  24. Doolittle DA, Atwell TD, Sanchez W, et al. Safety and Outcomes of Percutaneous Biopsy of 61 Hepatic Adenomas. AJR Am J Roentgenol. 2016;206:871-6.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jason R. Young.

Ethics declarations

Conflict of interest

No potential conflicts of interest or funding associated with this work.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Young, J.R., Graham, R.P., Venkatesh, S.K. et al. 18F-FDG PET/CT of hepatocellular adenoma subtypes and review of literature. Abdom Radiol 46, 2604–2609 (2021). https://doi.org/10.1007/s00261-021-02968-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-021-02968-2

Keywords

Navigation